Depression and Type 2 Diabetes

Edited by Khalida Ismail, Andreas Barthel, Stefan R. Bornstein, and Julio Licinio

Written and edited by a team of internationally recognized clinicians
Offers a unique perspective on the outstanding controversies of the epidemiology, mechanisms and treatment of the depression-type 2 diabetes comorbidity

Depression and Type 2 Diabetes

Edited by Khalida Ismail, Andreas Barthel, Stefan R. Bornstein, and Julio Licinio

Description

Type 2 diabetes is a major global health concern, and is predicted to affect between 10% to 25% of the world's population in the next 20 years. This epidemic is mostly attributed to ageing populations and unhealthy lifestyles. Thusly, understanding how the mind interacts with the body is essential in unlocking the psychological, biological, and sociocultural processes that increase the risk of type 2 diabetes and make it such a difficult condition to treat. Depression is a common co-morbid condition and when both conditions are present, this poses a significant challenge to patients, clinicians, and health care systems globally.

Depression and Type 2 Diabetes is a unique resource offering a fresh scientific approach to this frequent co-morbidity. Using the latest research and guidelines, this resource provides readers with a comprehensive overview of the subject at the different stages of human lifespan, from the uterine environment where the metabolic thermostat is first set, to growing old with diabetes.

Written and edited by international experts in diabetes and depression, Depression and Type 2 Diabetes reviews, critiques, and advances the latest research on the prevalent and complex relationship between depression and type 2 diabetes.

Depression and Type 2 Diabetes

Edited by Khalida Ismail, Andreas Barthel, Stefan R. Bornstein, and Julio Licinio

1. Global burden of diabetes and depression, Stefan F. Bornstein, Andreas Birkenfeld, and Julio Licinio
2. A lifecourse approach to understanding the association between depression and type 2 diabetes, Khalida Ismail, Calum D. Moulton, Andrea Danese, and Brenda W. Penninx
3. MicroRNAs as novel biomarkers in depression, diabetes and cardiovascular diseases, Henning Morawietz, Richard C. Siow, and Mohamad Musbah Almedawar
4. Genetics, Carol Kan and Ma-Li Wong
5. Innate immunity and inflammation in type 2 diabetes-associated depression, Calum D. Moulton and John Pickup
6. Hypothalamic-Pituitary-Adrenal (HPA) axis, Allan H. Young and Mario F. Jurena
7. Gut-brain axis: physiology, Carla Petrella, Giuseppe Nistico, and Robert Nistico
8. Diabetes distress, Norbert Hermanns, Marijke Bremmer, and Frank Snoek
9. The association between depression and cognitive impairment in type 2 diabetes, Calum Moulton and Clive Ballard
10. Treatment of depression in type 2 diabetes, Frank Petrak and Bonnie Rohrig
11. Risks and benefits of psychotropics, Andreas Barthel and Michael Bauer
12. Metabolic surgery and depression, Lidia Castagneto Gissey, James Casella Mariolo, Geltrude Mingrone, and Francesco Rubino
13. Novel pharmacological targets, Calum Moulton
14. Novel technologies, Harold Lebovitz and Shlomo Ben Haim
15. Current and emerging psychological models, Christopher Garrett
16. Targeting the circadian rhythm, Eleanor M Scott and Gregory Potter
17. Cultural and global perspectives, Kirsty Winkley, Ebaa Al-Ozairi, and Boon How Chew
18. National and international policy initiatives on multi-morbidity, Peter Schwarz and Patrick Timpel

Depression and Type 2 Diabetes

Edited by Khalida Ismail, Andreas Barthel, Stefan R. Bornstein, and Julio Licinio

Author Information

Khalida Ismail, Professor of Psychiatry and Medicine, Department of Psychological Medicine Institute of Psychiatry, Psychology and Neuroscience King's College London, London, UK,Andreas Barthel, Associate Professor of Medicine, Department of Medicine III, University Hospital Carl Gustav Carus, Dresden and Faculty of Medicine of the TU Dresden, Dresden, Germany,Stefan R. Bornstein, Professor of Medicine, Department of Medicine III, University Hospital Carl Gustav Carus, Dresden and Faculty of Medicine of the TU Dresden, Dresden, Germany,Julio Licinio, Deputy Director, College of Medicine, State University of New York, Upstate Medical University, Syracuse, USA

Contributors:

Mohamad Musbah Almedawar, Department of Medicine III, University Hospital Carl Gustav Carus, Germany

Ebaa Al-Ozairi, Faculty of Medicine, Health Sciences Centre, Kuwait

Andreas Barthel, Department of Medicine III, University Hospital Carl Gustav Carus, Germany and Medicover Bochum, Germany

Clive Ballard, University of Exeter Medical School, UK

Michael Bauer, Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Germany

Andreas L. Birkenfeld, Department of Medicine III, University Hospital Carl Gustav Carus, Dresden and Faculty of Medicine of the TU Dresden, Germany

Stefan R. Bornstein, Department of Medicine III, University Hospital Carl Gustav Carus, Germany

Marijke A. Bremmer, Department of Psychiatry, VU University Medical Centre, The Netherlands

Boon How Chew, Department of Family Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia (UPM), Serdang, Malaysia

Andrea Danese, MRC Social, Genetic and Developmental Psychiatry Centre and Department of Child & Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK

Christopher Garrett, Diabetes and Mental Health Group, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK

Lidia Castagneto Gissey, Surgical Sciences Department, Medical School, Sapienza University, Italy

Shlomo Ben Haim, Chairman Hobart Healthcare Group, UK

Norbert Hermanns, Research Institute of the Diabetes Academy Mergentheim, Germany

Khalida Ismail, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK

Mario F. Juruena, Centre for Affective Disorders- Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK

Carol Kan, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK

Harold E. Lebovitz, Professor of Medicine, State University of New York Health Science Center at Brooklyn, USA

Julio Licinio, College of Medicine, State University of New York, Upstate Medical University, USA

James Casella Mariolo, Surgical Sciences Department, Medical School, Sapienza University, Italy

Geltrude Mingrone, Department of Internal Medicine and 2General Surgery, Catholic University, Italy

Henning Morawietz, Department of Medicine III, University Hospital Carl Gustav Carus, Germany

Calum D. Moulton, Diabetes and Mental Health Group, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK

Giuseppe Nistico, European Brain Research Institute, 'Rita Levi-Montalcini' Foundation, Italy

Robert Nistico, European Brain Research Institute, Italy

Brenda W. Penninx, Department of Psychiatry, VU University Medical Center, The Netherlands

Carla Petrella, Institute of Cell Biology and Neurobiology, Italy

Frank Petrak, Department of Psychosomatic Medicine and Psychotherapy, LWL-University Clinic Bochum, Ruhr-University Bochum, Germany

John C. Pickup, Division of Diabetes and Nutritional Sciences, Faculty of Life Sciences and Medicine, King's College London, Guy's Hospital, UK

Gregory D. M. Potter, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, UK

Bonnie Rohrig, Department of Psychosomatic Medicine and Psychotherapy, LWL-University Clinic Bochum, Ruhr-University Bochum, Germany

Francesco Rubino, Department of Metabolic and Bariatric Surgery, Diabetes and Nutrition Science Division, King's College London, UK

Peter E. H. Schwarz, Department of Medicine III, University Hospital Carl Gustav Carus, Germany

Eleanor M. Scott, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, UK

Richard C. Siow, School of Cardiovascular Medicine & Sciences, King's British Heart Foundation Centre of Research Excellence, King's College London, UK

Frank J. Snoek, Department of Medical psychology, VU University Medical Center and Academic Medical Center, The Netherlands

Patrick Timpel, Department of Medicine III, University Hospital Carl Gustav Carus, Dresden and Faculty of Medicine of the TU Dresden, Germany

Kirsty Winkley, Florence Nightingale School of Nursing & Midwifery, King's College London, UK

Ma-Li Wong, South Australian Health and Medical Research Institute and Flinders University, Australia

Allan H. Young, Centre for Affective Disorders- Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK